(combination hormone blockade): also referred to as CHT, MAB, TAB or ADT (androgen deprivation therapy); therapy usually involving an LHRH agonist and an antiandrogen; may involve other agents such as Proscar® or prolactin inhibitors such as Dostinex®; preferred term is ADT with number attached to show number of agents e.g. ADT3 (Flutamide®, Lupron®, Proscar®) or ADT3 (FLP)